Advertisement

Topics

Latest "Precision Optics" News Stories

23:09 EST 17th November 2018 | BioPortfolio

Here are the most relevant search results for "Precision Optics" found in our extensive news archives from over 250 global news sources.

More Information about Precision Optics on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Precision Optics for you to read. Along with our medical data and news we also list Precision Optics Clinical Trials, which are updated daily. BioPortfolio also has a large database of Precision Optics Companies for you to search.

Showing "Precision Optics" News Articles 1–25 of 2,000+

Saturday 17th November 2018

Researchers combine technologies to view retina in unprecedented detail

By combining two imaging modalities — adaptive optics and angiography — investigators at the National Eye Institute (NEI) can see live neurons, epithelial cells, and blood vessels deep in the eye's light─sensing retina.


Precision Medicine Looks beyond DNA Sequences -- http://ow.ly/HmmN30mE1JM pic.twitter.com/CjNIM81ZfH

Precision Medicine Looks beyond DNA Sequences -- http://ow.ly/HmmN30mE1JM  pic.twitter.com/CjNIM81ZfH

Quanterix Corp QTRX Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryQuanterix Corp Quanterix is a life sciences company that develops and markets ultrasensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. The company develops platform based on its proprietary digital single molecule array, Simoa detection technology that allows the detection of proteins and nucleic acids in biological samples. Quan...


University of Rochester Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryUniversity of Rochester UOR is an educational university that offers research and development services. The university performs research in the areas of humanities, engineering medical education, medicine, geology, optics, economics, political theory, human behavior, and social and natural sciences. It offers various programs such as actuarial studies, American Sign Language, American studi...

Friday 16th November 2018

Precision Therapeutics Inc. (AIPT) CEO Dr. Carl Schwartz on Q3 2018 Results - Earnings Call Transcript

Global $85.5 Billion Precision Medicine (Diagnostics/Therapeutics) Market to 2025 - Key Players ...

DUBLIN, Nov. 16, 2018 /PRNewswire/ -- The "Precision Medicine (Diagnostics/Therapeutics) Market Analysis Report By Application (Genetic Tests, Esoteric Tests, Pharmaceuticals, Medical Devices), By End Use, Read more...

Global High Carbon Steel Wire Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Precision Medicine Looks beyond DNA Sequences -- http://ow.ly/7x1L30mE1Dp pic.twitter.com/Rfs0NDIcpH

Precision Medicine Looks beyond DNA Sequences -- http://ow.ly/7x1L30mE1Dp  pic.twitter.com/Rfs0NDIcpH

Elpis Biomed Wins Cambridge Start-Up of the Year

Chosen by Independent Expert Panel at the 2018 Cambridge Independent Science and Technology Awards Cambridge, UK, November 16, 2018 / B3C newswire / -- Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OPTi-OX platform, is pleased to announce that the Company has been selected as winner in the category Start-Up of the Year at the...

uBiome Awards Groundbreaking Grant to University of Denver to Study the Role of the Microbiome in Perinatal Depression

The leader in microbial genomics awards grant to University of Denver researchers to analyze association between microbiome composition, maternal mood, and infant behavior. SAN FRANCISCO (PRWEB) November 16, 2018 Through its Microbiome Grant Initiative, uBiome, the leader in microbial genomics, has awarded microbiome research support in study design, planning, sample collection, and analysis to t...

Hoya Corporation Strategy, SWOT and Corporate Finance Report [Report Updated: 01102018] Prices from USD $175

Hoya Corporation Strategy, SWOT and Corporate Finance ReportSummaryHoya Corporation Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsHoya Corporation Hoya or 'the company'...

The age of personalised medicine is coming

James Huang & Stephen Huang on the groundbreaking technologies that could change precision medicine in the near future

Kerr, Tannock on the 'Triangle of Mediocrity' Holding Oncology Back

With nearly 75 years of oncology experience between them, Drs Kerr and Tannock take aim at the pitfalls of precision medicine and the 'triangle of mediocrity' among academic medicine, pharma companies, and the FDA. Medscape Oncology

Thursday 15th November 2018

Insilico Medicine to present 'Cure a disease in a year' challenge at BioDataWorld 2018

(InSilico Medicine, Inc.) Insilico Medicine announces to present its research and introduce the 'Cure a disease in a year' program at the World's leading congress for big data in precision medicine -- Biodata World Congress 2018.

The OSA Foundation, Coherent Inc., Announce The Bernard J. Couillaud Prize

Award for early-career OSA members will support research projects in ultrafast photonics The Optical Society Foundation (OSAF) and Coherent, Inc. have created the Bernard J. Couillaud Prize, a merit-based award to support early-career OSA members who are engaged in ultrafast photonics research and application development. Each award will total $...

Dynex Technologies Receives CFDA Approval to Supply AGILITY Automated ELISA Processing System to China

Company’s portfolio approval demonstrates dedication to clinical labs in the Asia-Pacific region Dynex® Technologies, Inc., announced today that it received Chinese Food and Drug Administration (CFDA) approval to market its DYNEX AGILITY® instrument and software for quantitative immunoassay measurements of analytes, including proteins and mi...

Visiomed Group SA ALVMG Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummaryVisiomed Group SA Visiomed is a medical device company. The company develops and distributes electronic medical devices. It offers screening and diagnosis products, pain relief products, prevention and treatment products, hearing and optics, family hygiene, children's optics, baby bottle thermometer and others. Visiomed provides thermometers including contactless thermometers, auricular or ...

uBiome Awards Grant to Team of Urology Researchers at UCLA to Investigate Dietary Intervention in Prostate Cancer

The leader in microbial genomics awards grant to a team of researchers at the University of California Los Angeles to study effects on the microbiome due to fish oil consumption in men with prostate cancer. SAN FRANCISCO (PRWEB) November 15, 2018 Through its Microbiome Grant Initiative, uBiome, the leader in microbial genomics, has awarded microbiome research support in study design, planning, sa...

Beam Therapeutics Appoints Carole Ho, M.D., to Board of Directors

Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the appointment of Carole Ho, M.D., Chief Medical Officer and Head of Development at Denali Therapeutics, to the Company’s Board of Directors. “Carole has a remarkable track record in developing new medicines as well a...

Ra Pharmaceuticals Elects Bo Cumbo to Board of Directors

-- Mr. Cumbo, biotech industry veteran, brings commercial expertise and strategic leadership in industry-leading commercial product launches -- Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced the election of Bo Cumbo to its board of directors. Mr. Cumbo is a veteran of the biotechnology industry and has played strategically important roles in ...

TransEnterix Named to Deloitte’s Technology Fast 500

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced its naming to Deloitte’s 2018 Technology Fast 500TM, an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life sc...

Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies

Boehringer Ingelheim Expands Biomarker-driven Oncology Programs Alliance Enhances Epizyme’s Leadership in Oncology Epigenetics Boehringer Ingelheim and Epizyme, Inc. (Nasdaq: EPZM) today announced a new global collaboration focused on the research, development and commercialization of novel small molecule inhibitors d...

MyoKardia Inc MYOK Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryMyoKardia Inc MyoKardia is a clinical stage biopharmaceutical company. The company utilizes precision medicine platform to develop therapies for rare cardiovascular diseases including heritable cardiomyopathies. The company's pipeline products include therapeutic programs for the treatment of heritable cardiomyopathy including hypertrophic cardiomyopathy HCM and dilated cardiomyopathy DCM. ...

Precision, MaxCyte Enter Clinical Agreement

Allows Precision to use MaxCyte's Flow Electroporation® technologies to robustly deliver ARCUS genome-editing technology

Wednesday 14th November 2018

Rakuten Aspyrian Announces Appointment of Mickey Mikitani as Chief Executive Officer

SAN MATEO, Calif., Nov. 14, 2018 /PRNewswire/ -- Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, today announced Read more...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks